We are pleased to announce our Panel Discussion Topic and Guests:

    Opportunities and challenges of statistical programming to go digital


  • Meng Chen, AstraZeneca
    About Guest: Meng is currently Head of Biometrics in Astrazeneca R&D China. She leads a group of statisticians, programmers, data managers, medical writers together with business operation experts in AZ R&D China to help make innovative drugs available to the patients fast. She had over 16 years of industry experience having worked both in the US and China, on projects across many therapeutic areas and leading teams. Meng was trained as a statistician, and obtained her PhD in Statistics from University of Wisconsin-Madison.
  • Meng Chen, AstraZeneca

  • Ping-Chung Chang, Phastar
    About Guest: Mr. Ping-Chung Chang is currently the Head of China Development and Global Delivery at Phastar. Ping has been a biostatistician in the clinical industry since 2002 and has had worked for pharmaceutical, biotech and CRO companies through the years. Ping is an experienced leader in regulatory submissions, large global team operations and CRO business management. While his current career focus is business optimization, Ping has also been greatly interested in innovations that lead to effort reduction or process improvements, and has been a vocal leader for virtual trials, data visualization and advanced data monitoring methods.
  • Ping-Chung Chang, Phastar, China

  • Fan Xia, CSPC Pharmaceutical

    About Guest: Dr. Xia Fan is vice president of clinical development division and general manager of data science center of CSPC Pharmaceutical Group. In this role, she leads activities from biostatistics, statistical programming, and data management, as well as high-level supports formation and implementation of clinical development strategy for over 30 products. Prior to join CSPC, Dr. Xia has worked in Roche global product development, BeiGene and Zailab, and has successfully supported a number of global and local registrational clinical trials and FDA/EMA/CFDA submissions as project lead statistician or functional lead. Dr. Xia holds a bachelor's degree in statistics from Renmin University of China and a Ph.D. degree in statistics from the University of Hong Kong

  • Xia Fan, CSPC Pharmaceutical

  • Sina Djali, Jansen China R&D

    About Guest: Sina Djali has over 25 years of experience in drug and clinical development in various companies and academia. Currently he is the head of Integrated Clinical and Operations Analytics at Jansen China R&D. In this role Sina is responsible for strategic direction as well day to day activities of Data Management, Clinical and Statistical Programming, and Risk Management – Central Monitoring teams. Prior to this role, Sina was the head of Risk Management – Central Monitoring at Janssen R&D. Previously he has been responsible for Clinical Process and System Department at Tibotec Pharmaceuticals, where he developed and implemented a data driven Quality Risk Management System. He has also held several positions in research, regulatory affairs and R&D Quality Assurance departments at Wyeth and Aventis Pharmaceuticals.

  • Sina Djali, Jansen China R&D